Cytori shares slammed as safety concerns halt stem cell trials – FierceBiotech
|
Cytori shares slammed as safety concerns halt stem cell trials
FierceBiotech Cytori Therapeutics ($CYTX) hit the brakes on a pair of clinical trials to find out why three patients in the study suffered from "cerebrovascular" events after they were treated with the biotech's experimental stem cell treatment. The San Diego-based … Cytori halts stem cell study due to adverse events |
